The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Lyndsay N. Harris

333 Cedar St

WWW 213

Yale University

New Haven

USA

[email]@yale.edu

Name/email consistency: high

[Claim this account]

Affiliations

333 Cedar St, WWW 213, Yale University, New Haven, USA. 2009
Dana-Farber Cancer Institute. 2007
Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. 2006

References

Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013. Harris, L.N., Broadwater, G., Abu-Khalaf, M., Cowan, D., Thor, A.D., Budman, D., Cirrincione, C.T., Berry, D.A., Winer, E.P., Hudis, C.A., Hayes, D.F., Friedman, P., Ellis, M., Dressler, L. J. Clin. Oncol. (2009) [Pubmed]
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Harris, L.N., You, F., Schnitt, S.J., Witkiewicz, A., Lu, X., Sgroi, D., Ryan, P.D., Come, S.E., Burstein, H.J., Lesnikoski, B.A., Kamma, M., Friedman, P.N., Gelman, R., Iglehart, J.D., Winer, E.P. Clin. Cancer Res. (2007) [Pubmed]
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Harris, L.N., Broadwater, G., Lin, N.U., Miron, A., Schnitt, S.J., Cowan, D., Lara, J., Bleiweiss, I., Berry, D., Ellis, M., Hayes, D.F., Winer, E.P., Dressler, L. Breast Cancer Res. (2006) [Pubmed]